Microenvironment actuated t-cells and uses thereof
OwnerPedro Silberman, Kristen Vogt +2inventors
InventorsPedro Silberman, Kristen Vogt, David A. Scheinberg, James Han
Life of this patent
Estimating the term…
Loading patent…
OwnerPedro Silberman, Kristen Vogt +2inventors
InventorsPedro Silberman, Kristen Vogt, David A. Scheinberg, James Han
Estimating the term…
Disclosed herein are engineered T cells comprising (1) a chimeric receptor polypeptide comprising (a) an extracellular domain that specifically binds P-selectin; (b) a heterologous receptor polypeptide comprising one or more ligand-inducible proteolytic cleavage sites; and (c) an intracellular domain (ICD) comprising a transcriptional activator, wherein binding of the extracellular domain to P-selectin induces cleavage of the heterologous receptor polypeptide at the one or more ligand-inducible proteolytic cleavage sites to release the ICD, and (2) a CAR polypeptide encoded by a nucleic acid that is operably linked to a promoter that is responsive to the transcriptional activator of the released ICD.
An engineered T cell comprising
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A vector comprising
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.